Gavin Bennett

Company: Bicycle Therapeutics plc

Job title: Senior Director - Drug Development

Seminars:

Investigating the Clinical Performance of Zelenectide Pevedotin & BT5528 to Understand Class Effect Differences of Bicycle Toxin Conjugates Against Classical ADC Formats 8:30 am

• Laying out the emerging safety profiles of zelenectide pevedotin and BT5528, and comparing toxicity characterisation against classical ADC formats • Delving into BT5528 clinical toxicity profile against EphA2 in contrast to ADCs against the same target • Rationalising preclinical and clinical differences with PKPD analysis and understanding the advantages of BTCs design and performanceRead more

day: Conference Day Two pt 1